1018 related articles for article (PubMed ID: 28341427)
21. Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors.
Amit S; Mishali H; Kotlovsky T; Schwaber MJ; Carmeli Y
Clin Microbiol Infect; 2015 Jan; 21(1):30-4. PubMed ID: 25636924
[TBL] [Abstract][Full Text] [Related]
22. Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias.
Micozzi A; Gentile G; Minotti C; Cartoni C; Capria S; Ballarò D; Santilli S; Pacetti E; Grammatico S; Bucaneve G; Foà R
BMC Infect Dis; 2017 Mar; 17(1):203. PubMed ID: 28283020
[TBL] [Abstract][Full Text] [Related]
23. A multifaceted intervention strategy for eradication of a hospital-wide outbreak caused by carbapenem-resistant Klebsiella pneumoniae in Southern Israel.
Borer A; Eskira S; Nativ R; Saidel-Odes L; Riesenberg K; Livshiz-Riven I; Schlaeffer F; Sherf M; Peled N
Infect Control Hosp Epidemiol; 2011 Dec; 32(12):1158-65. PubMed ID: 22080653
[TBL] [Abstract][Full Text] [Related]
24. Spectrum and antibiotic resistance in community- and hospital-acquired urinary tract infections among adults: Experience from a large tertiary care center in a developing country.
Herbawi A; Abu Taha A; Aiesh BM; Sabateen A; Zyoud SH
Urologia; 2024 May; 91(2):394-402. PubMed ID: 38488375
[TBL] [Abstract][Full Text] [Related]
25. The clinical significance of carbapenem-resistant Klebsiella pneumoniae rectal colonization in critically ill patients: from colonization to bloodstream infection.
Kontopoulou K; Iosifidis E; Antoniadou E; Tasioudis P; Petinaki E; Malli E; Metallidis S; Vatopoulos A; Malisiovas N
J Med Microbiol; 2019 Mar; 68(3):326-335. PubMed ID: 30688629
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for carbapenem-resistant K. pneumoniae bloodstream infection and predictors of mortality in Chinese paediatric patients.
Zhang Y; Guo LY; Song WQ; Wang Y; Dong F; Liu G
BMC Infect Dis; 2018 May; 18(1):248. PubMed ID: 29855274
[TBL] [Abstract][Full Text] [Related]
27. Infection-prevention and control interventions to reduce colonisation and infection of intensive care unit-acquired carbapenem-resistant
Li M; Wang X; Wang J; Tan R; Sun J; Li L; Huang J; Wu J; Gu Q; Zhao Y; Liu J; Qu H
Antimicrob Resist Infect Control; 2019; 8():8. PubMed ID: 30651974
[TBL] [Abstract][Full Text] [Related]
28. Tigecycline for treatment of carbapenem-resistant Klebsiella pneumoniae infections after liver transplantation in the intensive care unit: a 3-year study.
Mouloudi E; Massa E; Piperidou M; Papadopoulos S; Iosifidis E; Roilides I; Theodoridou T; Kydona C; Fouzas I; Imvrios G; Papanikolaou V; Gritsi-Gerogianni N
Transplant Proc; 2014 Nov; 46(9):3219-21. PubMed ID: 25420864
[TBL] [Abstract][Full Text] [Related]
29. Carbapenem-resistant Klebsiella pneumoniae infections in kidney transplant recipients: a case-control study.
Simkins J; Muggia V; Cohen HW; Minamoto GY
Transpl Infect Dis; 2014 Oct; 16(5):775-82. PubMed ID: 25092500
[TBL] [Abstract][Full Text] [Related]
30. Tigecycline resistance among carbapenem-resistant Klebsiella Pneumoniae: Clinical characteristics and expression levels of efflux pump genes.
Chiu SK; Chan MC; Huang LY; Lin YT; Lin JC; Lu PL; Siu LK; Chang FY; Yeh KM
PLoS One; 2017; 12(4):e0175140. PubMed ID: 28388651
[TBL] [Abstract][Full Text] [Related]
31. A retrospective study of risk factors for carbapenem-resistant Klebsiella pneumoniae acquisition among ICU patients.
Hu Y; Ping Y; Li L; Xu H; Yan X; Dai H
J Infect Dev Ctries; 2016 Mar; 10(3):208-13. PubMed ID: 27031451
[TBL] [Abstract][Full Text] [Related]
32. Carbapenem-resistant Klebsiella pneumoniae in Barbados: Driving change in practice at the national level.
Forde C; Stierman B; Ramon-Pardo P; Dos Santos T; Singh N
PLoS One; 2017; 12(5):e0176779. PubMed ID: 28542162
[TBL] [Abstract][Full Text] [Related]
33. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K
Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972
[TBL] [Abstract][Full Text] [Related]
34. Urinary tract infections caused by community-acquired extended-spectrum β-lactamase-producing and nonproducing bacteria: a comparative study.
Dayan N; Dabbah H; Weissman I; Aga I; Even L; Glikman D
J Pediatr; 2013 Nov; 163(5):1417-21. PubMed ID: 23919903
[TBL] [Abstract][Full Text] [Related]
35. Does the urinary tract infection caused by carbapenem-resistant Gram-negative bacilli impact the outcome of kidney transplant recipients?
Freire MP; Mendes CV; Piovesan AC; de Paula FJ; Spadão F; Nahas WC; David-Neto E; Pierrotti LC
Transpl Infect Dis; 2018 Aug; 20(4):e12923. PubMed ID: 29797681
[TBL] [Abstract][Full Text] [Related]
36. [Community acquired urinary tract infection among hospitalized children in northern Israel: pathogens, susceptibility patterns and urinary tract anomalies].
Sakran W; Miron D; Halevy R; Colodner R; Smolkin V; Koren A
Harefuah; 2003 Apr; 142(4):249-52, 320, 319. PubMed ID: 12754871
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization: a case-case-control study.
Kofteridis DP; Valachis A; Dimopoulou D; Maraki S; Christidou A; Mantadakis E; Samonis G
J Infect Chemother; 2014 May; 20(5):293-7. PubMed ID: 24703709
[TBL] [Abstract][Full Text] [Related]
38. Outbreak of carbapenem-resistant Klebsiella pneumoniae in Puerto Rico associated with a novel carbapenemase variant.
Gregory CJ; Llata E; Stine N; Gould C; Santiago LM; Vazquez GJ; Robledo IE; Srinivasan A; Goering RV; Tomashek KM
Infect Control Hosp Epidemiol; 2010 May; 31(5):476-84. PubMed ID: 20334553
[TBL] [Abstract][Full Text] [Related]
39. Carbapenem-resistant Klebsiella pneumoniae colonization in pediatric and neonatal intensive care units: risk factors for progression to infection.
Akturk H; Sutcu M; Somer A; Aydın D; Cihan R; Ozdemir A; Coban A; Ince Z; Citak A; Salman N
Braz J Infect Dis; 2016; 20(2):134-40. PubMed ID: 26867474
[TBL] [Abstract][Full Text] [Related]
40. Carbapenem susceptibilities of Gram-negative pathogens in intra-abdominal and urinary tract infections: updated report of SMART 2015 in China.
Zhang H; Kong H; Yu Y; Wu A; Duan Q; Jiang X; Zhang S; Sun Z; Ni Y; Wang W; Wang Y; Liao K; Li H; Yang C; Huang W; Gui B; Shan B; Badal R; Yang Q; Xu Y
BMC Infect Dis; 2018 Sep; 18(1):493. PubMed ID: 30268102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
